{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0003-2187",
      "generic_name": "abatacept",
      "labeler_name": "E.R. Squibb & Sons, L.L.C.",
      "brand_name": "ORENCIA",
      "active_ingredients": [
        {
          "name": "ABATACEPT",
          "strength": "250 mg/15mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0003-2187-13",
          "description": "1 VIAL, SINGLE-USE in 1 CARTON (0003-2187-13)  / 15 mL in 1 VIAL, SINGLE-USE",
          "marketing_start_date": "20090101",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "E.R. Squibb & Sons, L.L.C."
        ],
        "rxcui": [
          "616015",
          "616018",
          "1145929",
          "1145932",
          "1799228",
          "1799230",
          "1925254",
          "1925255",
          "1925256",
          "1925257"
        ],
        "spl_set_id": [
          "0836c6ac-ee37-5640-2fed-a3185a0b16eb"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000008571",
          "N0000182159",
          "M0018640"
        ],
        "pharm_class_pe": [
          "Decreased Cytokine Activity [PE]"
        ],
        "pharm_class_epc": [
          "Selective T Cell Costimulation Modulator [EPC]"
        ],
        "pharm_class_cs": [
          "Recombinant Fusion Proteins [CS]"
        ],
        "unii": [
          "7D0YB67S97"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "spl_id": "962695b7-21f5-44bb-80e0-cb3b48c80be6",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20090101",
      "product_id": "0003-2187_962695b7-21f5-44bb-80e0-cb3b48c80be6",
      "application_number": "BLA125118",
      "brand_name_base": "ORENCIA",
      "pharm_class": [
        "Decreased Cytokine Activity [PE]",
        "Recombinant Fusion Proteins [CS]",
        "Selective T Cell Costimulation Modulator [EPC]"
      ]
    }
  ]
}